Paradigm to Introduce Upgrades to Its Dicon Perimeter at AAO Meeting in Chicago

   Paradigm Medical Industries, Inc. (PINKSHEETS: PDMI) announced today that it had completed the planned upgrades and improvements to its popular Dicon LD 400 Perimeter. The upgraded perimeter will be introduced at the annual American Academy of Ophthalmology (AAO) meeting to be held from October 14-17, 2010 in Chicago, Illinois. The upgraded perimeter will include the following improvements: (i) replacement of the floppy disc drive with an embedded memory; (ii) a new USB thumb drive for each of the 27 optional languages that may be used with the system; (iii) updated Advanced Fieldview software that is compatible with Windows Vista and Windows 7 operating systems; and (iv) a new USB printer port and appearance enhancements.

These new design improvements will be included on all new perimeter sales beginning on December 1, 2010 and thereafter. The new product will be sold as the Paradigm Dicon Autoperimeter, Model 500 and will replace the current Dicon LD 400 Perimeter. Paradigm also plans to offer through its service department similar upgrades to the LD 400's that are currently owned by purchasers.

"This development reflects the commitment of Paradigm's management to its customers and shareholders to continue to improve its existing products, and to develop and acquire new and innovative products that fit into Paradigm's growing portfolio of products designed to address many of the prevalent diseases of the eye, especially glaucoma," said Stephen Davis, President and Chief Executive Officer of Paradigm.

About Paradigm Medical Industries, Inc.

Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes ophthalmic diagnostic instruments and related products for early detection of glaucoma and other eye disorders. The Company's primary objective is to capture a niche market within the glaucoma and ultrasound microscopy fields. The Company markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States and internationally.

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.

Contact: Stephen L. Davis President and Chief Executive Officer 801-977-8970 www.paradigm-medical.com